Find policies, billing codes, payers, states, and providers
CPT 92004: Comprehensive Ophthalmological Evaluation, New Patient
CPT code 92004 represents a comprehensive ophthalmological evaluation for a new patient that includes a full medical eye examination and initiation of a diagnostic and treatment program spanning one or more visits. Nationally, this code is fundamental for billing initial ophthalmic medical consultations and is used across ophthalmology practices, particularly for patients presenting with complex or undiagnosed ocular conditions. Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of reimbursement and billing context for CPT code 92004, comparisons to related evaluation codes for new and established patients, common clinical indications that map to the code, and payer coverage notes. The publication also summarizes typical sites of service and the clinical scope of a comprehensive new-patient ophthalmologic exam. This analysis is intended for coding professionals, billing managers, and clinicians seeking a clear national-level reference on the use and clinical context of CPT code 92004.
Customize your policy alerts
Sign up for cpt 92004 policy alerts
Get alerted when payer policies referencing 92004 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 92004 describes a comprehensive ophthalmological evaluation for a new patient in which the provider performs a full medical eye examination and initiates a diagnostic and treatment program for one or more visits. This service involves a broad assessment of ocular health, refraction as appropriate, and formulation of a diagnostic and therapeutic plan.
-
Service type: Comprehensive ophthalmological evaluation, new patient
-
Typical site of service: Ophthalmology clinic or ambulatory eye care setting
National Reimbursement Benchmarks
Nationally, Medicare’s average allowed amount of $155.20 sits below BUCA’s mean commercial rate of $232.60, indicating that commercial contracts on average reimburse substantially higher for CPT 92004 than the Medicare baseline. Blue Cross Blue Shield and UnitedHealth Group have the highest mean levels among listed payers, while Aetna and Cigna are lower but not at Medicare’s level; BUCA’s mean represents a middle-to-upper commercial position versus Medicare.
Dispersion measured as P75 minus P25 is widest for Blue Cross Blue Shield at $113.00 (P75 $335.00 minus P25 $220.20), followed by UnitedHealth Group at $108.40 (P75 $232.90 minus P25 $124.50). Cigna shows a spread of $119.80 (P75 $239.40 minus P25 $119.60) actually slightly larger, while Aetna is tighter with a spread of $84.90 (P75 $172.70 minus P25 $84.80) and BUCA’s interquartile range is $108.80 (P75 $283.60 minus P25 $172.80). Medicare’s interquartile range is $15.00 (P75 $160.00 minus P25 $145.00), the narrowest of the group.